Andrew Laughhunn

Andrew Laughhunn is a highly experienced professional in the field of virology and analytical testing, currently serving as Senior Director of QC Analytical Testing at Forge Biologics since April 2023. Prior experience includes leading global pathogen safety innovation at CSL Behring, directing virology testing operations at WuXi Advanced Therapies, and overseeing viral assay development at Ultragenyx Pharmaceutical Inc. Andrew's robust background in virology research and quality control is complemented by a Bachelor's Degree in Microbiology from The Ohio State University, a Master of Science in Medical Microbiology and Cell Biology from the University of Florida, and a Doctor of Philosophy in Healthcare Genetics from Clemson University. Andrew's expertise is further demonstrated through his foundational roles in various organizations, contributing to regulatory submissions and optimizing results for therapeutic products.